Assessment of Adverse Events and Their Ability to Discriminate Response to Anti-PD-1/PD-L1 Antibody Immunotherapy.

McLeod, Howard L; Mariam, Arshiya; Schveder, Kimberly A; Rotroff, Daniel M

McLeod, Howard L; Mariam, Arshiya; Schveder, Kimberly A; Rotroff, Daniel M.

Afiliación

McLeod HL; Howard L. McLeod, PharmD, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL; and Arshiya Mariam, Kimberly A. Schveder, and Daniel M. Rotroff, PhD, MSPH, Lerner Research Institute, Cleveland Clinic, Cleveland, OH.
Mariam A; Howard L. McLeod, PharmD, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL; and Arshiya Mariam, Kimberly A. Schveder, and Daniel M. Rotroff, PhD, MSPH, Lerner Research Institute, Cleveland Clinic, Cleveland, OH.
Schveder KA; Howard L. McLeod, PharmD, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL; and Arshiya Mariam, Kimberly A. Schveder, and Daniel M. Rotroff, PhD, MSPH, Lerner Research Institute, Cleveland Clinic, Cleveland, OH.
Rotroff DM; Howard L. McLeod, PharmD, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL; and Arshiya Mariam, Kimberly A. Schveder, and Daniel M. Rotroff, PhD, MSPH, Lerner Research Institute, Cleveland Clinic, Cleveland, OH.

J Clin Oncol ; 38(1): 103-104, 2020 01 01.

Article en En | MEDLINE | ID: mdl-31675248

Asunto(s)

Antígeno B7-H1; Inmunoterapia; Anticuerpos; Humanos

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Antígeno B7-H1 / Inmunoterapia Tipo de estudio: Prognostic_studies Límite: Humans Idioma: En Revista: J Clin Oncol Año: 2020 Tipo del documento: Article Pais de publicación: Estados Unidos

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google